Preparation and characterization of budesonide loaded nanoparticles for ocular delivery to retina via subconjunctival route.
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: PANDIT, Jayamanti (Jamia Hamdard, Pharmaceutics, Delhi, India)
- Co-author(s): Sultana, Yasmin (Jamia Hamdard, Delhi, India)
Diabetic retinopathy (DR) remains a leading cause of visual disability and blindness in the developed world. Blindness usually results from retinal damages if not treat early in diabetic eye. Currently DR is treated with laser photocoagulation and virectomy. Intravitreal steroids and intravitreal anti-VEGF therapy are being used as second line.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.